Psychosocial Outcomes and Transition Readiness in JIA
Describing Relationships Between Psychosocial Outcomes and Readiness for Transition in Adolescent and Young Adult Patients With Juvenile Idiopathic Arthritis - a Pilot Study
1 other identifier
observational
120
1 country
1
Brief Summary
It is widely acknowledged that the transition from paediatric to adult health services should be a multidimensional and multidisciplinary process that addresses the medical, psychosocial, and educational needs of adolescents and young adults (AYA). Despite this, there is currently a scarcity of research examining the relationships between psychosocial factors (e.g., anxiety, social support) and transition readiness in AYA with juvenile idiopathic arthritis (JIA). This study therefore aimed to examine the relationships between psychosocial factors and transition readiness in pre-transfer adolescents and post-transfer young adults aged 10-25 years diagnosed with JIA at a single centre. In total, 40 adolescents aged 10-16 years together with a parent/guardian, will take part at Sheffield Children's Hospital and 40 young adults aged 16-25 years will take part at Sheffield Teaching Hospitals. Participants will be asked to complete a battery of self-report questionnaire measuring psychosocial factors (anxiety/depression, social support, family functioning, health-related quality of life) and transition readiness (transition knowledge and skills, self-efficacy). JIA disease severity was also measured during clinic appointments. This study has received full ethical approval, and all participants will give their written informed assent or consent before taking part. The results from this research will be important in better understanding which psychosocial factors affect how ready young people with JIA feel to move from paediatric to adult rheumatology services. We hope this research will inform further work to help target psychological interventions in this group of patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 18, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 18, 2018
CompletedFirst Submitted
Initial submission to the registry
May 21, 2018
CompletedFirst Posted
Study publicly available on registry
January 2, 2020
CompletedJanuary 2, 2020
December 1, 2019
11 months
May 21, 2018
December 31, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Generalised Anxiety
Generalised Anxiety Disorder-7 Questionnaire (Spitzer et al., 2006)
1 day
Secondary Outcomes (6)
Depression
1 day
Health-related quality of life
1 day
Social support
1 day
Family functioning
1 day
Prosocial and problem behaviours
1 day
- +1 more secondary outcomes
Study Arms (3)
Pre-Transfer Patients aged 10-16 years
Post-Transfer Patients aged 16-25 years
Parents/Guardians of Pre-Transfer Patients
Eligibility Criteria
The study population will be patients aged 10-25 years or parents/guardians of patients aged 10-16 years who have a diagnosis of juvenile idiopathic arthritis.
You may qualify if:
- Aged 10-25 years
- Diagnosis of juvenile idiopathic arthritis (including all ILAR subtypes except 'systemic arthritis' and 'undifferentiated arthritis')
- Juvenile idiopathic arthritis managed by Sheffield Children's Hospital or Sheffield Teaching Hospitals
- Fluent in verbal and written English
You may not qualify if:
- Aged \<10 years or \>25 years
- Diagnosis of juvenile idiopathic arthritis ILAR subtypes 'systemic arthritis' or 'undifferentiated arthritis')
- Diagnosis of uveitis
- Non-fluent in verbal and written English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sheffield Children's NHS Foundation Trust
Sheffield, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 21, 2018
First Posted
January 2, 2020
Study Start
May 24, 2017
Primary Completion
April 18, 2018
Study Completion
April 18, 2018
Last Updated
January 2, 2020
Record last verified: 2019-12